Companies: 10,795·Total market cap: $144.5T
Novavax, Inc.

Novavax, Inc.

NVAXNASDAQHealthcare● Active
$8.92
$-0.57(-6.01%)
Market Cap$1.5B
P/E Ratio
52W High$11.97
52W Low$6.13

Novavax, Inc.(NVAX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NVAX · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$1.12B$0.68B$0.56B$1.60B$0.20B
Cost of Revenue$0.07B$0.20B$0.34B$0.90B$0.00B
Gross Profit$1.05B$0.48B$0.21B$0.70B$0.20B
Gross Margin %(computed)93.67%70.28%38.21%43.55%100.00%
Operating Expenses
R&D Expenses$0.34B$0.39B$0.74B$1.24B$2.53B
G&A Expenses$0.00B$0.00B$0.00B$0.49B$0.30B
Total Operating Expenses$0.49B$0.73B$0.78B$1.34B$1.88B
Operating Income$0.56B($0.25B)($0.57B)($0.64B)($1.69B)
Operating Margin %(computed)50.14%-36.49%-101.82%-40.32%-853.61%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.02B$0.02B$0.01B$0.02B$0.02B
Income Before Tax$0.44B($0.18B)($0.54B)($0.65B)($1.71B)
Income Tax Expense$0.00B$0.01B$0.00B$0.00B$0.03B
Net Income$0.44B($0.19B)($0.55B)($0.66B)($1.74B)
Net Margin %(computed)39.19%-27.49%-97.97%-41.15%-882.55%
Per Share & EBITDA
EPS (Basic)$2.72$-1.23$-5.41$-8.42$-23.44
Wtd Avg Shares0.16B0.15B0.10B0.08B0.07B
EBITDA$0.49B($0.11B)($0.49B)($0.60B)($1.68B)
EBITDA Margin %(computed)43.82%-15.84%-87.60%-37.82%-850.66%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Novavax, Inc.

关于Novavax, Inc.(NVAX)损益表

Novavax, Inc.(NVAX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NVAX实现营收$1.12B,毛利润$1.05B(毛利率93.67%),净利润$0.44B(净利率39.19%)。

常见问题

NVAX · 4 问

Novavax, Inc.(NVAX)2025财年营收为$1.12B,同比up64.7%。

NVAX revenueNVAX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08